내부자 거래

EDGAR

SBC Medical Group Holdings Incorporated

이사, 임원 및 10% 이상 주주가 SEC 양식 3, 4, 5로 보고한 거래이며, 각 제출 문서의 XML에서 읽었습니다. 코드와 그 설명은 SEC의 원문입니다.

양식 4는 거래 후 영업일 2일 이내에 제출해야 하므로 가장 최근 거래는 아직 제출되지 않았을 수 있습니다.

기간: 2025년 11월 20일 이후 날짜의 거래.

공개시장 매수(코드 P)
거래 0건, —주
공개시장 매도(코드 S)
거래 3건, 7,987,900주
주식 수 × 주당 가격의 합계: 20,151,760.5

합계는 나열된 제출 거래를 더한 것이며, 보고된 내용을 센 것일 뿐 방향을 나타내지 않습니다.

5건 중 1–5건 표시

SEC 양식 3, 4, 5에 제출된 내부자 거래(최신순)
날짜보고자코드취득 또는 처분주식 수주당 가격(제출된 대로)가치(산출)거래 후 보유 주식 수직접 또는 간접규칙 10b5-1 체크란주석출처
2026년 4월 28일 2026년 4월 29일 제출Aikawa Yoshiyuki Director · Officer: Chairman and CEO · 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock
처분(D)465,0003.0225
1,405,462.5

산출: 주식 수 × 주당 가격. 정확한 값 1405462.5000.

78,839,460직접(D) 아니요
F1
  • F1 The price of $3.0225 represents the net price received per share of common stock of SBC Medical Group Holdings Incorporated (SBC shares), which were sold by the Reporting Person, on the closing date of April 28, 2026, pursuant to the underwriters' option to purchase additional shares in connection with an underwritten public offering that initially closed on April 21, 2026.
제출 문서 열기 0001493152-26-019703 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 4월 21일 2026년 4월 23일 제출Aikawa Yoshiyuki Director · Officer: Chairman and CEO · 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock
처분(D)3,100,0003.0225
9,369,750

산출: 주식 수 × 주당 가격. 정확한 값 9369750.0000.

79,304,460직접(D) 아니요
F1
  • F1 The price of $3.0225 represents the net price received per share of common stock of SBC Medical Group Holdings Incorporated (SBC shares), which were sold by the Reporting Person pursuant to an underwritten public offering that closed on April 21, 2026.
제출 문서 열기 0001493152-26-018813 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 3월 6일 2026년 3월 10일 제출Aikawa Yoshiyuki Director · Officer: Chairman and CEO · 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Stock
처분(D)4,422,9002.12
9,376,548

산출: 주식 수 × 주당 가격. 정확한 값 9376548.00.

861,600간접(I) By Aikawa Equity Management Co., Ltd.아니요
F1, F2, F3, F4
  • F1 Reflects the sale pursuant to separate share purchase agreements (the Purchase Agreements) by the Reporting Person of shares of Aikawa Equity Management Co., Ltd. (AEM) to certain consultants providing services to medical corporations that have entered into contractual and service arrangements with subsidiaries of the Issuer. AEM directly holds 5,284,500 shares of Issuer common stock (SBC shares), and each share of AEM corresponds to one hundred SBC shares. The number reported reflects the number of SBC shares held by AEM that corresponds with AEM shares sold by the Reporting Person as described above. No actual SBC shares were sold by the Reporting Person or AEM.
  • F2 The sales price reported herein is based on the JPY 33,417 price per AEM share, divided by 100 and converted from Japanese yen to United States dollars at an exchange rate of JPY 157.640= US$1.00, which was the foreign exchange rate on March 6, 2026, as reported by the U.S. Federal Reserve in its weekly release on March 9, 2026.
  • F3 Reflects the transfer of 5,284,500 and 5,000,000 SBC shares by the Reporting Person to each of AEM and GODO Kaisha Aikawa Investment (GODO), respectively, each of which was a wholly owned subsidiary of the Reporting Person at the time of such transfer. As a result of the sales pursuant to the Purchase Agreements, the Reporting Person no longer controls AEM, and therefore, disclaims beneficial ownership over the SBC shares held by AEM, except to the extent of his pecuniary interest therein.
  • F4 The 861,600 SBC shares reported as indirectly beneficially owned by the Reporting Person through AEM reflects the Reporting Person's indirect interest that he may be deemed to have shared beneficial ownership over following the transactions described herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.
제출 문서 열기 0001493152-26-009608 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 3월 6일 2026년 3월 10일 제출Aikawa Yoshiyuki Director · Officer: Chairman and CEO · 10% owner
J

Other acquisition or disposition (describe transaction)

파생증권: Put Options (Right to Sell) — 기초자산 Common Stock (4,422,900) — 행사가 2.12
처분(D)44,229——44,229간접(I) By Aikawa Equity Management Co., Ltd.아니요
F2, F5, F1
  • F2 The sales price reported herein is based on the JPY 33,417 price per AEM share, divided by 100 and converted from Japanese yen to United States dollars at an exchange rate of JPY 157.640= US$1.00, which was the foreign exchange rate on March 6, 2026, as reported by the U.S. Federal Reserve in its weekly release on March 9, 2026.
  • F5 In connection with the sales described herein, pursuant to the terms of the Purchase Agreements, if the price per SBC share falls below a certain price threshold on or after April 1, 2029, the consultants described above may request the Reporting Person to redeem all shares for the same amount as the purchase price described above.
  • F1 Reflects the sale pursuant to separate share purchase agreements (the Purchase Agreements) by the Reporting Person of shares of Aikawa Equity Management Co., Ltd. (AEM) to certain consultants providing services to medical corporations that have entered into contractual and service arrangements with subsidiaries of the Issuer. AEM directly holds 5,284,500 shares of Issuer common stock (SBC shares), and each share of AEM corresponds to one hundred SBC shares. The number reported reflects the number of SBC shares held by AEM that corresponds with AEM shares sold by the Reporting Person as described above. No actual SBC shares were sold by the Reporting Person or AEM.
제출 문서 열기 0001493152-26-009608 제출 문서의 XML에서 읽음 이 행에 이의 제기
2026년 3월 6일 2026년 3월 10일 제출Aikawa Yoshiyuki Director · Officer: Chairman and CEO · 10% owner
J

Other acquisition or disposition (describe transaction)

파생증권: Call Options (Right to Buy) — 기초자산 Common Stock (4,422,900) — 행사가 2.12
취득(A)44,229——44,229간접(I) By Aikawa Equity Management Co., Ltd.아니요
F2, F6, F1
  • F2 The sales price reported herein is based on the JPY 33,417 price per AEM share, divided by 100 and converted from Japanese yen to United States dollars at an exchange rate of JPY 157.640= US$1.00, which was the foreign exchange rate on March 6, 2026, as reported by the U.S. Federal Reserve in its weekly release on March 9, 2026.
  • F6 In connection with the sales described herein, pursuant to the terms of the Purchase Agreements, upon satisfaction of certain conditions, the Reporting Person has the right to repurchase the AEM shares from the consultants (which were acquired as described above) for the same amount as the purchase price described above.
  • F1 Reflects the sale pursuant to separate share purchase agreements (the Purchase Agreements) by the Reporting Person of shares of Aikawa Equity Management Co., Ltd. (AEM) to certain consultants providing services to medical corporations that have entered into contractual and service arrangements with subsidiaries of the Issuer. AEM directly holds 5,284,500 shares of Issuer common stock (SBC shares), and each share of AEM corresponds to one hundred SBC shares. The number reported reflects the number of SBC shares held by AEM that corresponds with AEM shares sold by the Reporting Person as described above. No actual SBC shares were sold by the Reporting Person or AEM.
제출 문서 열기 0001493152-26-009608 제출 문서의 XML에서 읽음 이 행에 이의 제기

기관 보유자(양식 13F)

저장소에 이 발행사로 연결된 양식 13F 보유 내역이 없습니다. 아직 연결되지 않았거나 제출하지 않은 보유자는 0이 아니라 없는 것입니다.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% 보유자(스케줄 13D, 13G)

SEC 구조화 형식(2024년 말 이후)으로 제출된 스케줄을 여기서 읽습니다. 이전 스케줄은 자유 텍스트여서 읽지 않습니다.

5% 보유자, 최신 사건순, 제출된 대로
보유자해당 종류 대비 비율보유 주식 수사건일양식출처
Yoshiyuki Aikawa Common Stock, $0.0001 par value per share82.284,304,460.0004/19/2026 2026년 4월 21일 제출SCHEDULE 13D/A정정 3제출 문서 열기 0001493152-26-018402 이 행에 이의 제기
Aikawa Equity Management Co., Ltd. Common Stock, $0.0001 par value per share5.25,284,500.0003/06/2026 2026년 3월 13일 제출SCHEDULE 13G제출 문서 열기 0001493152-26-010132 이 행에 이의 제기
Yoshiyuki Aikawa Common Stock, $0.0001 par value per share85.287,404,460.0003/06/2026 2026년 3월 10일 제출SCHEDULE 13D/A정정 2제출 문서 열기 0001493152-26-009606 이 행에 이의 제기

비율은 제출 문서가 지정한 종류에 대한 것이며 보유자가 밝힌 그대로입니다. 그룹 구성원은 각자 그룹의 주식을 보고하므로 행을 합산하지 않습니다.

읽은 내용

2004년 6월 14일부터 2026년 11월 19일까지의 제출 문서 2,660,713건을 읽음: 양식 3, 3/A, 4, 4/A, 5, 5/A.

아카이브를 아직 읽는 중이라 일부 연도는 불완전할 수 있습니다. 여기서 제출 수가 적은 해가 실제로 적게 제출되었다는 뜻은 아닙니다.

제출 연도별 읽은 문서
제출 연도읽은 문서
201577,800
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,123

SEC가 XML을 요구하기 전의 제출 문서는 목록에만 있고 내용은 추출하지 않습니다.

SBC Medical Group Holdings Incorporated(으)로 돌아가기